Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SQUEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEZE!!!!!!!!!!!!!!!!!!!!!!!!!
19M VOLUME TODAY SAYS YOU'RE RIGHT
TOO MUCH FKN DILUTION.
IT WILL COME.......AND MORE
He continued, "We are very encouraged by the anatomical and histological data from our esophageal implant study. Based on these data, we believe that our second generation implant possesses all the necessary cues to elicit full regeneration of the esophagus. Importantly, our esophageal implant addresses a very significant need as a potentially life-saving treatment for patients with esophageal cancer. Each year in the U.S. approximately 17,000 new cases of esophageal cancer are diagnosed, and more than 4,000 are addressed by surgery. Our results underscore the value and potential of our platform technology to treat these patients and pave the way for further studies and our regulatory pathway for human clinical trials."
Hmmmmm,,,,,I wonder who's updating their twitter page
It was a shock to see and tells me the CEO was listening closely to our advice!
https://twitter.com/urbanbarns
,,,,,,,It was Nice to see that tweet!
NO SECONDARY NEWS WEEEEEEEEEEEEE! POOR TWITTER CLOWNS HAHAAA!
He continued, "We are very encouraged by the anatomical and histological data from our esophageal implant study. Based on these data, we believe that our second generation implant possesses all the necessary cues to elicit full regeneration of the esophagus. Importantly, our esophageal implant addresses a very significant need as a potentially life-saving treatment for patients with esophageal cancer. Each year in the U.S. approximately 17,000 new cases of esophageal cancer are diagnosed, and more than 4,000 are addressed by surgery. Our results underscore the value and potential of our platform technology to treat these patients and pave the way for further studies and our regulatory pathway for human clinical trials."
$1.52 AH GREAT CALL GENIUS!!!!!!!!!!!!!!!!!! $3 SOON
NO CHIT....MAXIM WAS THE GUY ON THE CALL ASKING QUESTIONS. I'LL BET THEY WILL INITIATE A NEWER RATING SOON.
ONE NEWER THAN YOUR POS THESTREET RATING
HOW DID THAT ONE WORK OUT FOR YOU!!!!!
POOR FOOLS!!!
*HART:NASD WHO REMEMBERS SUMMER STREET $24 TARGET:
4/10/2014 Summer Street Initiated Coverage Buy $24.00
3/14/2014 Maxim Group Initiated Coverage Buy $19.00
http://www.marketbeat.com/stocks/NASDAQ/HART/
*HART:NASD WHO REMEMBERS SUMMER STREET $24 TARGET:
4/10/2014 Summer Street Initiated Coverage Buy $24.00
3/14/2014 Maxim Group Initiated Coverage Buy $19.00
http://www.marketbeat.com/stocks/NASDAQ/HART/
WHO REMEMBERS SUMMER STREET $24 TARGET:
4/10/2014 Summer Street Initiated Coverage Buy $24.00
3/14/2014 Maxim Group Initiated Coverage Buy $19.00
http://www.marketbeat.com/stocks/NASDAQ/HART/
UP UP AND AWAY!!!!!!!!!!! $3-$5
****HART:NASD**He continued, "We are very encouraged by the anatomical and histological data from our esophageal implant study. Based on these data, we believe that our second generation implant possesses all the necessary cues to elicit full regeneration of the esophagus. Importantly, our esophageal implant addresses a very significant need as a potentially life-saving treatment for patients with esophageal cancer. Each year in the U.S. approximately 17,000 new cases of esophageal cancer are diagnosed, and more than 4,000 are addressed by surgery. Our results underscore the value and potential of our platform technology to treat these patients and pave the way for further studies and our regulatory pathway for human clinical trials."
****HART:NASD**He continued, "We are very encouraged by the anatomical and histological data from our esophageal implant study. Based on these data, we believe that our second generation implant possesses all the necessary cues to elicit full regeneration of the esophagus. Importantly, our esophageal implant addresses a very significant need as a potentially life-saving treatment for patients with esophageal cancer. Each year in the U.S. approximately 17,000 new cases of esophageal cancer are diagnosed, and more than 4,000 are addressed by surgery. Our results underscore the value and potential of our platform technology to treat these patients and pave the way for further studies and our regulatory pathway for human clinical trials."
He continued, "We are very encouraged by the anatomical and histological data from our esophageal implant study. Based on these data, we believe that our second generation implant possesses all the necessary cues to elicit full regeneration of the esophagus. Importantly, our esophageal implant addresses a very significant need as a potentially life-saving treatment for patients with esophageal cancer. Each year in the U.S. approximately 17,000 new cases of esophageal cancer are diagnosed, and more than 4,000 are addressed by surgery. Our results underscore the value and potential of our platform technology to treat these patients and pave the way for further studies and our regulatory pathway for human clinical trials."
GOING OVER $3....I'D RUN AWAY TOO IF I JUST EMBARRASSED MYSELF!!!!!
He continued, "We are very encouraged by the anatomical and histological data from our esophageal implant study. Based on these data, we believe that our second generation implant possesses all the necessary cues to elicit full regeneration of the esophagus. Importantly, our esophageal implant addresses a very significant need as a potentially life-saving treatment for patients with esophageal cancer. Each year in the U.S. approximately 17,000 new cases of esophageal cancer are diagnosed, and more than 4,000 are addressed by surgery. Our results underscore the value and potential of our platform technology to treat these patients and pave the way for further studies and our regulatory pathway for human clinical trials."
YOU CAN CATCH THE PLAYBACK CALL! LATER ON...
DO YOU KNOW how many Esophageal cancers this will give hope to patients that have small chance of survival
HART~~~IMAGINE THAT....LUNG CANCER AND FULL REGENERATION OF ESOPHAGUS
HART~~~IMAGINE THAT....LUNG CANCER AND FULL REGENERATION OF ESOPHAGUS
Esophageal cancers FULL REGENERATION
IMAGINE THAT....LUNG CANCER AND FULL REGENERATION OF ESOPHAGUS
LUNG CANCER LEAD PRODUCT FULL REGENERATION OF ESOPHAGUS
WHAT FOOL SAYS LUNG CANCER IS NOT IMPORTANT!!!!! HAHAAA! AND FULL REGENERATION OF ESOPHAGUS IS NOTHING
MAYO CLINIC UNDERSTANDS THAT'S WHAT COUNTS...
"FULL REGENERATION OF ESOPHAGUS"
MY DAD IS SURGEON FOOL! LUNG CANCER..AND IMPACT OF THE AIRWAY
--TALKING ABOUT: Lung cancer and the tracheal bronchus lung cancer market
--TALKING ABOUT: Esophageal cancer 6th highest rate
YUP! AND LISTENING TO THE CONFERENCE CALL NOW....
READ THEIR TWITTER,,,,THEY SHUT DOWN THESE CLOWNS PRONTO!!!! HAHAAAA!
https://twitter.com/CatalystIR